Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chadi Hage Chehade

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Cancer Cell|April 26, 2024
Molecular subtypes as potential biomarkers in renal cell carcinomaChadi Hage Chehade, Neeraj Agarwal
Cancer Discovery|January 12, 2024
Bispecific T-cell Engagers in Metastatic Castration-Resistant Prostate CancerChadi Hage Chehade, Georges Gebrael, Neeraj Agarwal
Med (New York, N.Y.)|November 9, 2024
[<sup>89</sup>Zr]Zr-girentuximab PET-CT imaging to diagnose, characterize, and differentiate clear-cell renal cell carcinomaChadi Hage Chehade, Georges Gebrael, Neeraj Agarwal
Med (New York, N.Y.)|February 15, 2025
On-treatment PSA kinetics as a potential biomarker: Guiding personalized treatment in metastatic hormone-sensitive prostate cancerZeynep Irem Ozay, Chadi Hage Chehade, Neeraj Agarwal
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2024
Targeting the FGFR Pathway in Patients with Advanced Solid TumorsChadi Hage Chehade, Zeynep Irem Ozay, Neeraj Agarwal
Life (Basel, Switzerland)|February 24, 2024
PARP Inhibitors in Metastatic Castration-Resistant Prostate Cancer: Unraveling the Therapeutic LandscapeAshaar Al-Akhras, Chadi Hage Chehade, Arshit Narang, et al.
Expert Opinion on Pharmacotherapy|August 30, 2024
Talazoparib for the treatment of prostate cancerArshit Narang, Chadi Hage Chehade, Zeynep Irem Ozay, et al.
Therapeutic Advances in Medical Oncology|March 26, 2026
Antibody-drug conjugates in prostate cancer: current landscape and future directionsZeynep Irem Ozay, Chadi Hage Chehade, Georges Gebrael, et al.
European Urology|March 12, 2025
T-cell Engagers in Prostate CancerChadi Hage Chehade, Zeynep Irem Ozay, Micah Ostrowski, et al.
IJID Regions|March 19, 2026
Navigating Candidemia in a tertiary hospital: A 4-year epidemiologic and clinical reviewChadi Hage Chehade, Bassem Habr, Carine Harmouche, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Cancer Cell|April 26, 2024
Molecular subtypes as potential biomarkers in renal cell carcinomaChadi Hage Chehade, Neeraj Agarwal
Cancer Discovery|January 12, 2024
Bispecific T-cell Engagers in Metastatic Castration-Resistant Prostate CancerChadi Hage Chehade, Georges Gebrael, Neeraj Agarwal
Med (New York, N.Y.)|November 9, 2024
[<sup>89</sup>Zr]Zr-girentuximab PET-CT imaging to diagnose, characterize, and differentiate clear-cell renal cell carcinomaChadi Hage Chehade, Georges Gebrael, Neeraj Agarwal
Med (New York, N.Y.)|February 15, 2025
On-treatment PSA kinetics as a potential biomarker: Guiding personalized treatment in metastatic hormone-sensitive prostate cancerZeynep Irem Ozay, Chadi Hage Chehade, Neeraj Agarwal
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2024
Targeting the FGFR Pathway in Patients with Advanced Solid TumorsChadi Hage Chehade, Zeynep Irem Ozay, Neeraj Agarwal
Life (Basel, Switzerland)|February 24, 2024
PARP Inhibitors in Metastatic Castration-Resistant Prostate Cancer: Unraveling the Therapeutic LandscapeAshaar Al-Akhras, Chadi Hage Chehade, Arshit Narang, et al.
Expert Opinion on Pharmacotherapy|August 30, 2024
Talazoparib for the treatment of prostate cancerArshit Narang, Chadi Hage Chehade, Zeynep Irem Ozay, et al.
Therapeutic Advances in Medical Oncology|March 26, 2026
Antibody-drug conjugates in prostate cancer: current landscape and future directionsZeynep Irem Ozay, Chadi Hage Chehade, Georges Gebrael, et al.
European Urology|March 12, 2025
T-cell Engagers in Prostate CancerChadi Hage Chehade, Zeynep Irem Ozay, Micah Ostrowski, et al.
IJID Regions|March 19, 2026
Navigating Candidemia in a tertiary hospital: A 4-year epidemiologic and clinical reviewChadi Hage Chehade, Bassem Habr, Carine Harmouche, et al.
Pageof 3